Post-operative neuromuscular function of patients receiving non-depolarising muscle relaxants at Universitas Hospital, Bloemfontein, South Africa
Abstract
Objectives: To determine the number of patients whose non-depolarising muscle relaxation is adequately reversed. To define factors that contribute to reversal Design: A cross sectional study. Setting: Universitas Hospital recovery room over a 2 month period.
Subjects: Patients that received non-depolarising muscle relaxants and who gave informed consent.
Outcome measures: A quantitative train-of-four (TOF) ratio was determined within 5 to 15 minutes after arrival in the recovery room.
Results: Recovery to TOF greater than 0.9: 57.1% [95% CI 44.8%; 68.9%] patients. Recovery to TOF greater than 0.8: 82.9% [95% CI 72.0%; 90.8%] patients. More patients who received vecuronium recovered to a TOF smaller than 0.8 compared with atracurium and cis-atracurium (Fisher’s exact test, p=0.0151).
Conclusions: The muscle relaxation of many patients is not fully reversed in the recovery room, despite a long time lapse since the last drug administration, as well as the administration of neostigmine.
Subjects: Patients that received non-depolarising muscle relaxants and who gave informed consent.
Outcome measures: A quantitative train-of-four (TOF) ratio was determined within 5 to 15 minutes after arrival in the recovery room.
Results: Recovery to TOF greater than 0.9: 57.1% [95% CI 44.8%; 68.9%] patients. Recovery to TOF greater than 0.8: 82.9% [95% CI 72.0%; 90.8%] patients. More patients who received vecuronium recovered to a TOF smaller than 0.8 compared with atracurium and cis-atracurium (Fisher’s exact test, p=0.0151).
Conclusions: The muscle relaxation of many patients is not fully reversed in the recovery room, despite a long time lapse since the last drug administration, as well as the administration of neostigmine.